UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Circulating cell-free microRNAs as clinical cancer biomarkers

Biomolecular concepts, 2017-05, Vol.8 (2), p.61-81

2017

Link zum Volltext

Verfügbarkeit prüfen

Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages

European respiratory review, 2020-03, Vol.29 (155), p.190052

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-11, Vol.137, p.1-6

2019

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma

Oncotarget, 2017-06, Vol.8 (23), p.38056-38060

2017

Link zum Volltext

Verfügbarkeit prüfen

Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges

Cancers, 2021-07, Vol.13 (15), p.3759

2021

Link zum Volltext

Verfügbarkeit prüfen

Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies

Nature communications, 2024-06, Vol.15 (1), p.5345-15, Article 5345

2024

Link zum Volltext

Verfügbarkeit prüfen

Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer

Cancers, 2022-05, Vol.14 (11), p.2613

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy

Acta dermato-venereologica, 2019-02, Vol.99 (2), p.206-210

2019

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis, biology and epidemiology of oligometastatic breast cancer

Breast (Edinburgh), 2021-10, Vol.59, p.144-156

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.GS3-05-GS3-05

2022

Link zum Volltext

Verfügbarkeit prüfen

Loss of RhoB Expression in Human Lung Cancer Progression

Clinical cancer research, 2004-04, Vol.10 (8), p.2742-2750

2004

Link zum Volltext

Verfügbarkeit prüfen

Cytoplasmic p27Kip1 promotes tumorigenesis via suppression of RhoB activity

The Journal of pathology, 2019-01, Vol.247 (1), p.60-71

2019

Link zum Volltext

Verfügbarkeit prüfen

RhoB Protects Human Keratinocytes from UVB-induced Apoptosis through Epidermal Growth Factor Receptor Signaling

The Journal of biological chemistry, 2005-12, Vol.280 (52), p.43257-43263

2005

Link zum Volltext

Verfügbarkeit prüfen

Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude Mice

The Journal of biological chemistry, 2000-06, Vol.275 (24), p.17974-17978

2000

Link zum Volltext

Verfügbarkeit prüfen

RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer

Clinical cancer research, 2014-12, Vol.20 (24), p.6541-6550

2014

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic regulation of RhoB loss of expression in lung cancer

BMC cancer, 2007-11, Vol.7 (1), p.220-220, Article 220

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular biomarkers for lung adenocarcinoma

The European respiratory journal, 2017-04, Vol.49 (4), p.1601734-1601734

2017

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Lung cancer (Amsterdam, Netherlands), 2018-06, Vol.120, p.108-112

2018

Link zum Volltext

Verfügbarkeit prüfen

MAP1A Light Chain-2 Interacts with GTP-RhoB to Control Epidermal Growth Factor (EGF)-dependent EGF Receptor Signaling

The Journal of biological chemistry, 2008-02, Vol.283 (7), p.4155-4164

2008

Link zum Volltext

Verfügbarkeit prüfen

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

The lancet oncology, 2022-11, Vol.23 (11), p.1367-1377

2022

Link zum Volltext

Verfügbarkeit prüfen

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS -mutated lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2016-10, Vol.100, p.1-4

2016

Link zum Volltext

Verfügbarkeit prüfen

Competitive Inhibition of Choline Phosphotransferase by Geranylgeraniol and Farnesol Inhibits Phosphatidylcholine Synthesis and Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells

The Journal of biological chemistry, 1998-10, Vol.273 (40), p.26179-26186

1998

Link zum Volltext

Verfügbarkeit prüfen

Size and Concentration of Cell-Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction

Analytical chemistry (Washington), 2023-06, Vol.95 (24), p.9263-9270

2023

Link zum Volltext

Verfügbarkeit prüfen

RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription

The Journal of biological chemistry, 2000-10, Vol.275 (40), p.31001-31008

2000

Link zum Volltext

Verfügbarkeit prüfen

RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers

Small GTPases, 2018-07, Vol.9 (4), p.339-344

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(107)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(58)
Humans
(45)
Animals
(27)
Life Sciences
(26)
Oncology
(25)
Mice
(20)
Female
(16)
Biochemistry & Molecular Biology
(13)
Biological And Medical Sciences
(13)
Mutation
(13)
Lung Cancer
(12)
Tumors
(12)
Cell Biology
(11)
Enzyme Inhibitors - Pharmacology
(11)
Tumor Cells, Cultured
(11)
Rhob Gtp-Binding Protein - Metabolism
(10)
Lung Neoplasms - Pathology
(9)
Medical Sciences
(9)
Pharmacology. Drug Treatments
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Circulating cell-free microRNAs as clinical cancer biomarkers

Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer

Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma

Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges

Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies

Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy

Diagnosis, biology and epidemiology of oligometastatic breast cancer

Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial

Loss of RhoB Expression in Human Lung Cancer Progression

Cytoplasmic p27Kip1 promotes tumorigenesis via suppression of RhoB activity

RhoB Protects Human Keratinocytes from UVB-induced Apoptosis through Epidermal Growth Factor Receptor Signaling

Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude Mice

RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer

Epigenetic regulation of RhoB loss of expression in lung cancer

Molecular biomarkers for lung adenocarcinoma

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

MAP1A Light Chain-2 Interacts with GTP-RhoB to Control Epidermal Growth Factor (EGF)-dependent EGF Receptor Signaling

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS -mutated lung adenocarcinoma

Competitive Inhibition of Choline Phosphotransferase by Geranylgeraniol and Farnesol Inhibits Phosphatidylcholine Synthesis and Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells

Size and Concentration of Cell-Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction

RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription

RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers

Suchergebnisse filtern